DCM
CRBP icon

Driehaus Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Driehaus Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-127,787
Closed -$2.64M – 401
2024
Q3 		$2.64M Buy
127,787
+64,728
+103% +$3.31M 0.02% 294
2024
Q2 		$2.85M Hold
63,059
– – 0.03% 281
2024
Q1 		$2.47M Buy
+63,059
New +$1.55M 0.02% 297

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Driehaus Capital Management's CRBP Position: Q4 2024 in Review

Driehaus Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q4 2024, closing a stake of 127,787 shares — an estimated $2.64M sold.

Driehaus Capital Management first reported a position in CRBP in Q1 2024 and held it in 3 quarters. The position peaked at $2.85M in Q2 2024. 99 funds tracked by Wall St. Rank hold CRBP as of Q4 2024.

  • Driehaus Capital Management reported no remaining Corbus Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 127,787 Corbus Pharmaceuticals shares in Q4 2024, an estimated $2.64M.
  • Driehaus Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Driehaus Capital Management's Corbus Pharmaceuticals position peaked at $2.85M in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.